The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML-Reference-Cited by-同舟云学术

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML

Published:2019-10 Issue:40 Volume:98 Page:e17406
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yang Yuan,Tang Zengwei,An Tianli,Zhao Li

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference46 articles.

1. Iron overload in patients with myelodysplastic syndromes: an updated overview;Moukalled;Cancer,2018

2. Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy;Schuler;Ann Hematol,2018

3. Acute Myeloid Leukemia;Dohner;N Engl J Med,2015

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

5. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study;Alessandrino;Haematologica,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of adiposity, adipokines and polymorphisms of leptin and adiponectin in myelodysplastic syndromes;British Journal of Nutrition;2023-10-19

2. Supportive Care for Patients With Myelodysplastic Syndromes;The Cancer Journal;2023-05

3. Research Progress of Serum Ferritin in the Treatment of Adult Acute Myeloid Leukemia;Advances in Clinical Medicine;2023

4. Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2022-09

5. EnvIRONmental Aspects in Myelodysplastic Syndrome;International Journal of Molecular Sciences;2021-05-14